Cargando…
CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a prevalent complication of extreme obesity. Loading of the liver with fat can progress to inflammation and fibrosis including cirrhosis. The molecular factors involved in the progression from simple steatosis to fibrosis remain poorly understo...
Autores principales: | Chu, Xin, Jin, Qunyan, Chen, Hui, Wood, G. Craig, Petrick, Anthony, Strodel, William, Gabrielsen, Jon, Benotti, Peter, Mirshahi, Tooraj, Carey, David J., Still, Christopher D., DiStefano, Johanna K., Gerhard, Glenn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937820/ https://www.ncbi.nlm.nih.gov/pubmed/29690903 http://dx.doi.org/10.1186/s12967-018-1490-y |
Ejemplares similares
-
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
por: Wood, G. Craig, et al.
Publicado: (2017) -
Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery
por: Still, Christopher D., et al.
Publicado: (2014) -
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
por: Lent, Michelle R., et al.
Publicado: (2017) -
Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity
por: Gerhard, Glenn S., et al.
Publicado: (2014) -
An electronic health record-enabled obesity database
por: Wood, G Craig, et al.
Publicado: (2012)